Literature DB >> 17650447

Factors influencing cytomegalovirus seropositivity in stem cell transplant patients and donors.

Per Ljungman1, Ronald Brandan.   

Abstract

CMV status of the donor and the recipient influence the outcome of allogeneic stem cell transplantation. To study factors determining CMV status, 40,311 patients and 23,048 donors were identified in the EBMT registry. Logistic regression models predicting seropositivity were constructed. Female patients were more likely to be seropositive (p<0.001). The risk increased with age (p<0.001) but decreased according to the year of transplant (p<0.001). There were differences in the probability of seropositivity between patients from different countries. Adjusted for patient serostatus, the risk of a donor being seropositive was higher in females (p<0.001) and older donors (p<0.001).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17650447     DOI: 10.3324/haematol.11061

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  5 in total

1.  Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall.

Authors:  M Noviello; A Forcina; V Veronica; R Crocchiolo; M T L Stanghellini; M Carrabba; R Greco; L Vago; F Giglio; A Assanelli; M R Carbone; Z Magnani; F Crippa; C Corti; M Bernardi; J Peccatori; C Bordignon; F Ciceri; C Bonini; A Bondanza
Journal:  Bone Marrow Transplant       Date:  2015-06-15       Impact factor: 5.483

2.  Cytomegalovirus: pathogen, paradigm, and puzzle.

Authors:  Michael Boeckh; Adam P Geballe
Journal:  J Clin Invest       Date:  2011-05       Impact factor: 14.808

3.  Scoring system for clinically significant CMV infection in seropositive recipients following allogenic hematopoietic cell transplant: an SFGM-TC study.

Authors:  David Beauvais; Elodie Drumez; Didier Blaise; Régis Peffault de Latour; Edouard Forcade; Patrice Ceballos; Anne Uyttebroeck; Hélène Labussière; Stéphanie Nguyen; Jean-Henri Bourhis; Patrice Chevallier; Anne Thiebaut; Xavier Poiré; Sébastien Maury; Eric Deconinck; Thomas Cluzeau; Eolia Brissot; Anne Huynh; Marie-Thérèse Rubio; Alain Duhamel; Ibrahim Yakoub-Agha
Journal:  Bone Marrow Transplant       Date:  2020-12-18       Impact factor: 5.483

Review 4.  Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation.

Authors:  Jan Styczynski
Journal:  Infect Dis Ther       Date:  2017-12-04

5.  Cytomegalovirus infection may be oncoprotective against neoplasms of B-lymphocyte lineage: single-institution experience and survey of global evidence.

Authors:  Marko Janković; Aleksandra Knežević; Milena Todorović; Irena Đunić; Biljana Mihaljević; Ivan Soldatović; Jelena Protić; Nevenka Miković; Vera Stoiljković; Tanja Jovanović
Journal:  Virol J       Date:  2022-09-29       Impact factor: 5.913

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.